Lexaria Bioscience Corp expected to post a loss of 8 cents a share - Earnings Preview
Lexaria Bioscience Corp <LEXX.OQ> expected to post a loss of 8 cents a share - Earnings Preview
Lexaria Bioscience Corp LEXX.OQ LEXX.O is expected to show a fall in quarterly revenue when it reports results on July 13 (estimated) for the period ending May 31 2026
The Kelowna British Columbia-based company is expected to report a 71.3% decrease in revenue to $50 thousand from $174 thousand a year ago, according to the mean estimate from 2 analysts, based on LSEG data.
LSEG's mean analyst estimate for Lexaria Bioscience Corp is for a loss of 8 cents per share.
The one available analyst rating on the shares is "buy".
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Lexaria Bioscience Corp is $3.75, about 509.8% above its last closing price of $0.62
This summary was machine generated July 10 at 12:37 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)